Evidence map›Paper›PMID 39965200›Full record

ArticleJMIR research protocols2025

Effectiveness of Composite Ayurveda Regimen in a Black Box Design for the Management of Rheumatoid Arthritis: Protocol of a Single Arm, Community-Based Study.

Deepa Makhija, Sunita Mata, Abha Sharma, Kalpana Kachare, Aparna Manathottathil, Seema Jain, Sophia Jameela, Bhogavalli Chandrasekhara Rao, Rakesh Rana, Arunabh Tripathi and 5 more

Abstract readClinical Trial Protocol
In one paragraph

Article in JMIR research protocols, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Deepa MakhijaCentral Council for Research in Ayurvedic Sciences, New Delhi, India.ORCID 0000-0003-1607-5966
Sunita MataCentral Council for Research in Ayurvedic Sciences, New Delhi, India.ORCID 0000-0002-4878-7602
Abha SharmaCentral Council for Research in Ayurvedic Sciences, New Delhi, India.ORCID 0000-0001-9413-9131
Kalpana KachareCentral Council for Research in Ayurvedic Sciences, New Delhi, India.ORCID 0000-0001-6320-1174
Aparna ManathottathilCentral Council for Research in Ayurvedic Sciences, New Delhi, India.ORCID 0009-0006-1551-0611
Seema JainCentral Ayurveda Research Institute, Delhi, India.ORCID 0000-0002-5450-0292
Sophia JameelaCentral Council for Research in Ayurvedic Sciences, New Delhi, India.ORCID 0000-0001-6685-3610
Bhogavalli Chandrasekhara RaoCentral Council for Research in Ayurvedic Sciences, New Delhi, India.ORCID 0000-0001-5408-3225
Rakesh RanaCentral Council for Research in Ayurvedic Sciences, New Delhi, India.ORCID 0000-0002-3115-0701
Arunabh TripathiCentral Council for Research in Ayurvedic Sciences, New Delhi, India.ORCID 0000-0001-7235-4236
Kiran RanaCentral Council for Research in Ayurvedic Sciences, New Delhi, India.ORCID 0009-0002-1389-7921
Vandana JoshiCentral Council for Research in Ayurvedic Sciences, New Delhi, India.ORCID 0009-0008-2146-4839
Anukampa SinghCentral Council for Research in Ayurvedic Sciences, New Delhi, India.ORCID 0009-0009-6092-3150
Narayanam SrikanthCentral Council for Research in Ayurvedic Sciences, New Delhi, India.ORCID 0000-0002-3976-4978
Rabinarayan AcharyaCentral Council for Research in Ayurvedic Sciences, New Delhi, India.ORCID 0000-0003-4413-1937

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRheumatoid arthritis (RA) is an autoimmune disease that affects joints and can have extra-articular manifestations. RA usually tends to be progressive and leads to substantial health care burdens, both in terms of disability and economic costs. Despite the various treatment modalities available, there is still an urgent need for safe and effective medicine based on the pattern of disease presentation. The increasing interest in complementary and alternative medicine has created a demand for extensive research in this area.

objectiveThis clinical study is designed to evaluate the effectiveness and tolerability of a composite Ayurveda regimen in RA.

methodsThe study is a single-arm (pre-post design), community-based interventional study with a black box design being conducted at 6 study centers. A total of 240 participants aged between 18 and 65 years, diagnosed with RA as per the 2010 American College of Rheumatology and the European League Against Rheumatism criteria are recruited as per the selection criteria. All the participants received Ayush-SG and Rasnasaptak Kashaya for 84 days along with customized treatment as per the disease presentation and associated complaints. The outcome measures include the change in disease activity score (DAS)-28 with erythrocyte sedimentation rate, disease-specific biochemical and inflammatory markers, Disability Index score, change in the participant's assessment of pain and frequency of use of conventional analgesics or nonsteroidal anti-inflammatory drugs from baseline. The tolerability of interventions is assessed through the occurrence of adverse events. Categorical variables will be analyzed with McNemar chi-square test, and continuous variables will be assessed using the paired t test or Wilcoxon test for pre-post assessment. The level of significance will be 5%.

resultsThe recruitment of participants was initiated in December 2023. The participant recruitment was completed in March 2024 and out of 240 participants enrolled, 222 (92.5%) completed the study up to the last follow-up. Data verification, compilation, and analysis are under process. After data analysis, the study's findings will be published in a peer-reviewed journal.

conclusionsThis interventional study that incorporates the black box approach may provide a strong framework for managing RA. This design is a more reliable method for evaluating the effectiveness and tolerability of the composite Ayurveda regimen in RA.

trial registrationClinical Trial Registry-India CTRI/2023/06/054203; https://tinyurl.com/4prvwr6z. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/57918.

Indexed as

Arthritis, RheumatoidMedicine, AyurvedicAdolescentAdultAgedFemaleHumansMaleMiddle AgedMulticenter Studies as TopicTreatment OutcomeYoung AdultAmavataAyush-SG (coded drug)Rasnasaptak Kashayarheumatoid arthritis

Identifiers

PMID39965200
PMCPMC11888095

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.